News | January 29, 2024
Jubilant Pharmova Singapore to sell its entire 25.8% stake in Sofie Biosciences, USA
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Bridging the gap between histopathology and molecular pathology
The facility has been set up to manufacture tuberculosis testing cartridges
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
Subscribe To Our Newsletter & Stay Updated
